Company / Shareholders' Equity
Biohaven Ltd. Shareholders' Equity History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$423.4M
FY2024
5-year range
$16.8M / $538.8M
FY2020-FY2024
Trend
-1.1%
vs FY2023
Sector context
#105 of 213
Health Care
What the data says
At $423M, Biohaven Ltd.'s shareholders' equity ranks #105 of 213 in the Health Care sector. Declined from $539M to $423M over the past 2 years.
Based on SEC 10-K filings.
$423M in FY2024 with a 3-year CAGR of +130.2%.
Declined from $539M to $423M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +130.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 213 in Health CareTop 49% of 213This company $423.4M Sector average $2.5B
▼
-83.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +130.2%, indicating consistent growth.
- In FY2024, shareholders' equity decreased 1.1% year-over-year.
- Ranks #105 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $423.4M | -1.1% |
| FY2023 | $428.0M | -20.6% |
| FY2022 | $538.8M | +1453.1% |
| FY2021 | $34.7M | +106.7% |
| FY2020 | $16.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026